• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Alembic Pharmaceuticals Limited — Updates, 07-11-2025: Press Release

    07-11-2025 | 03:04 pm

    Alembic Pharma secures USFDA final approval for its Sumatriptan Injection autoinjector, a significant new drug-device combo. This product targets an estimated US$ 73 million market, enhancing Alembic's US presence.

    No comments yet. Be the first to comment!

    All announcements from Alembic Pharmaceuticals Limited